697802-67-8

Basic information

• Product Name: 5-Heptynoic acid, 7-[2-oxo-6-[(1E)-3-oxo-4-phenyl-1-butenyl]-1-piperidinyl]-, methyl ester
• CAS NO: 697802-67-8
• Molecular Formula: C23H27NO4
• Molecular Weight: 381.472
• Mol File: 697802-67-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-Heptynoic acid, 7-[2-oxo-6-[(1E)-3-oxo-4-phenyl-1-butenyl]-1-piperidinyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Heptynoic acid, 7-[2-oxo-6-[(1E)-3-oxo-4-phenyl-1-butenyl]-1-piperidinyl]-, methyl ester(697802-67-8)
• EPA Substance Registry System: 5-Heptynoic acid, 7-[2-oxo-6-[(1E)-3-oxo-4-phenyl-1-butenyl]-1-piperidinyl]-, methyl ester(697802-67-8)

Safety Data

• Hazardous Substances Data: 697802-67-8(Hazardous Substances Data)

Upstream product

• 861690-76-8 7-(2-Formyl-6-oxo-piperidin-1-yl)-hept-5-ynoic acid methyl ester 
• 52343-38-1 dimethyl 2-oxo-3-phenylpropylphosphonate 

Downstream Products

• 697802-69-0 (Z)-7-[2-oxo-6-((E)-3-oxo-4-phenyl-but-1-enyl)-piperidin-1-yl]-hept-5-enoic acid methyl ester 

Relevant articles and documents

Treatment of inflammatory bowel disease

The present invention provides a method of treating inflammatory bowel disease which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula 1; wherein X

Piperidinyl prostaglandin E analogs

The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; wher